Pavonine Co., Ltd. (KOSDAQ:177830)
2,760.00
-5.00 (-0.18%)
At close: Apr 30, 2026
Pavonine Revenue
In the year 2025, Pavonine had annual revenue of 132.54B KRW, down -0.21%. Pavonine had revenue of 30.17B in the quarter ending December 31, 2025, a decrease of -5.93%.
Revenue
132.54B
Revenue Growth
-0.21%
P/S Ratio
0.24
Revenue / Employee
566.41M
Employees
234
Market Cap
31.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 132.54B | -284.66M | -0.21% |
| Dec 31, 2024 | 132.83B | 12.14B | 10.06% |
| Dec 31, 2023 | 120.68B | 2.65B | 2.24% |
| Dec 31, 2022 | 118.04B | -8.23B | -6.52% |
| Dec 31, 2021 | 126.26B | -2.55B | -1.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAMJIN | 148.32B |
| Booster | 120.76B |
| NBT Inc. | 92.31B |
| PN Poong Nyun | 56.04B |
| Shinjin Sm | 54.44B |
| Alticast | 53.17B |
| HANBIT SOFT | 37.89B |
| NGeneBio | 21.24B |